Thrive Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Sell |
5,567
-413
| -7% | -$76.7K | 0.17% | 70 |
|
|
2025
Q1 | $1.25M | Sell |
5,980
-222
| -4% | -$46.5K | 0.24% | 49 |
|
|
2024
Q4 | $1.1M | Buy |
6,202
+42
| +0.7% | +$7.46K | 0.2% | 58 |
|
|
2024
Q3 | $1.22M | Sell |
6,160
-7
| -0.1% | -$1.38K | 0.22% | 57 |
|
|
2024
Q2 | $1.06M | Sell |
6,167
-196
| -3% | -$33.6K | 0.21% | 56 |
|
|
2024
Q1 | $1.16M | Buy |
6,363
+578
| +10% | +$105K | 0.24% | 52 |
|
|
2023
Q4 | $896K | Sell |
5,785
-331
| -5% | -$51.3K | 0.2% | 66 |
|
|
2023
Q3 | $912K | Buy |
6,116
+544
| +10% | +$81.1K | 0.24% | 55 |
|
|
2023
Q2 | $751K | Buy |
5,572
+1,034
| +23% | +$139K | 0.19% | 76 |
|
|
2023
Q1 | $723K | Buy |
4,538
+76
| +2% | +$12.1K | 0.19% | 69 |
|
|
2022
Q4 | $721K | Buy |
4,462
+965
| +28% | +$156K | 0.21% | 60 |
|
|
2022
Q3 | $469K | Buy |
3,497
+106
| +3% | +$14.2K | 0.16% | 82 |
|
|
2022
Q2 | $519K | Buy |
3,391
+318
| +10% | +$48.7K | 0.18% | 73 |
|
|
2022
Q1 | $498K | Buy |
3,073
+723
| +31% | +$117K | 0.15% | 80 |
|
|
2021
Q4 | $318K | Buy |
+2,350
| New | +$318K | 0.11% | 117 |
|